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Natural products are the most historically significant
source of compounds for drug development. How-
ever, unacceptably high rates of compound redis-
covery associated with large-scale screening of
common microbial producers have resulted in the
abandonment of many natural product drug discov-
ery efforts, despite the increasing prevalence of clin-
ically problematic antibiotic resistance. Screening of
underexplored taxa represents one strategy to avoid
rediscovery. Herein we report the discovery, isola-
tion, and structural elucidation of streptomonomicin
(STM), an antibiotic lasso peptide from Streptomo-
nospora alba, and report the genome for its pro-
ducing organism. STM-resistant clones of Bacillus
anthracis harbor mutations towalR, the gene encod-
ing a response regulator for the only known widely
distributed and essential two-component signal
transduction system in Firmicutes. To the best of
our knowledge, Streptomonospora had been hith-
erto biosynthetically and genetically uncharacter-
ized, with STM being the first reported compound
from the genus. Our results demonstrate that
understudied microbes remain fruitful reservoirs
for the rapid discovery of novel, bioactive natural
products.
INTRODUCTION
Microbial biosynthesis represents the most important historical
source of chemical matter for the understanding of biology
and the development of medicines (Newman and Cragg,
2012). However, despite the value of natural products as
medicinal leads, the frequent rediscovery of known compounds
renders traditional screening methods (i.e. bioassay-guidedChemistry & Biology 22, 241isolation) increasingly unappealing and economically disadvan-
tageous (Baltz, 2006). In response, a number of modern natural
product discovery strategies have been developed, including
genome-guided discovery (Doroghazi et al., 2014), antibiotic
resistance-mediated isolation (Thaker et al., 2014), reactivity-
based screening (Cox et al., 2014), PCR-based strain prioritiza-
tion (Hindra et al., 2014), mass spectrometry-based network
analysis (Nguyen et al., 2013), heterologous expression (Feng
et al., 2010), and metagenomics (Kang and Brady, 2013) with
the general aim of reducing the burden of rediscovery and
thereby accelerating the drug discovery process.
In widely studied organisms, it is frequently the case that the
abundant natural products are already known; undiscovered
compounds are often believed to be silent or at least below a
detection threshold. This can complicate identification, purifica-
tion, structural elucidation, and efforts to determine the mecha-
nism of action. Moreover, broad metabolic and bioinformatic
analysis shows that natural product biosynthetic capability
tends to parallel bacterial speciation (Doroghazi et al., 2014);
hence, rather than concentrating solely on screening many
strains of one particular known producing species, it may
also be useful to seek new species in underexplored taxa.
Understudied organisms—those that can be cultivated in
the laboratory yet unsequenced or metabolically uncharacter-
ized—thus present the prospect of discovery of novel, abun-
dant bioactive metabolites with lower rates of rediscovery (Pidot
et al., 2014). Among these organisms are the Streptomonospora,
a genus within the family Nocardiopsaceae (Cui et al., 2001).
Members of the genus are slow-growing halophiles, typically
requiring cultivation for a month or more in high-salt medium
(10%–25% w/v NaCl). At least nine distinct Streptomonospora
species have been reported; however, no corresponding
genome sequences are available. These characteristics have
rendered Streptomonospora sp. markedly unattractive both
from the standpoint of traditional high-throughput natural prod-
uct screening campaigns and more modern genome-driven dis-
covery efforts. Perhaps for this reason, the biosynthetic capacity
of the Streptomonospora has gone entirely neglected in the 13
years since their first description. As actinomycetes in general–250, February 19, 2015 ª2015 Elsevier Ltd All rights reserved 241
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Figure 1. Mass Spectrometry Analysis
(A) MALDI-TOF mass spectrum of an extract of Streptomonospora alba YIM 90003 showing the compound as the dominant peak (m/z 2256, [M + Na]+).
(B) Anm/z scan of purified STM that was directly infused into an 11 T FT-MS resulted in a 2+ charge ion consistent with the calculatedm/z for STM (Figure S2A).
The ion was fragmented and produced the resulting spectra. A diagram of STM is shown with the observed b- and y- ions labeled on the structure and in the
spectra.
(C) Anm/z scan of purified, carboxypeptidase Y- and thermolysin-digested STM that was directly infused into an 11 T FT-MS resulted in a 1+ charge ion consistent
with the 10 N-terminal residues of STM (Figure S2B). The ion was fragmented and produced the resulting spectra. A diagram of carboxypeptidase Y- and
thermolysin-digested STM is shown with the observed b- and y- ions labeled on the structure and in the spectra.
See also Figures S1 and S2.have been shown to be unusually talented biosynthetic chem-
ists, we reasoned that investigating an understudied, yet trac-
table, genus would shed light on the natural product repertoire
of these organisms and guide future genome-mining programs.
Taking into account the above, we cultured Streptomono-
spora alba YIM 90003 (Li et al., 2003) and found an abundant nat-
ural product, streptomonomicin (STM), which was isolated and
subjected to structural and biological characterization. We also
performed whole-genome sequencing of S. alba, revealing
STM’s biosynthetic origin and shedding light on the biosynthetic
capability of the genus.
RESULTS AND DISCUSSION
Isolation of Streptomonomicin
The MALDI-TOF mass spectra of intact S. alba YIM 90003 cells
and a nonlyticmethanol extract were dominated by the presence
of an intense peak (m/z 2256 [M + Na]+), indicating an abundant,
exported natural product (Figure 1A). Extracts from the organism
were fractionated using a C18 Sep-Pak and the resulting
fractions containing m/z 2256 displayed antibacterial activity
against Bacillus subtilis in a preliminary bioassay. Accordingly,
we named the compound streptomonomicin, and by subjecting
MeOH extracts of scaled-up cultures of S. alba to purification via
C18 Sep-Pak and high-performance liquid chromatography
(HPLC), isolated additional material for structural elucidation
and further refinement of bioactivity (Figure S1). Yields obtained
on solid media ranged from 10 to 14 mg/l.
Structure Elucidation of Streptomonomicin
The structure of STM was determined by the synergistic use of
mass spectrometry (MS), nuclear magnetic resonance (NMR)
spectroscopy, amino acid analysis, and genome sequencing.
The compoundwas submitted to a full suite of NMR experiments
(1H; 1H-1H double quantum filter correlation spectroscopy
[DQF-COSY], total correlation spectroscopy [TOCSY], nuclear242 Chemistry & Biology 22, 241–250, February 19, 2015 ª2015 ElseOverhauser effect spectroscopy [NOESY]; 1H-13C heteronuclear
single-quantum correlation spectroscopy [HSQC], and hetero-
nuclear multiple-bond correlation spectroscopy [HMBC]; Fig-
ure S3) as well as high-resolution Fourier transform (FT) MS/
MS analysis (Figure 1; Figure S2). The FT-MS/MS data (Figure 1;
Figure S2) and 1H-1H TOCSY (Figure S3I) revealed STM to be
a peptide, consistent with its UV absorbance spectrum (Fig-
ure S1C). Analysis of the TOCSY spectrum revealed the pres-
ence of 21 amino acids, which were predominantly hydrophobic:
three each Leu/Ile/Tyr/Ser/Pro, two Gly, two Asx (one Asn, one
Asp, as determined later), one Ala, one Val (Figure S3I; Table
S1). This amino acid composition was consistent with subse-
quent quantitative amino acid (QAA) analysis (Table S2). Mild hy-
drolysis and chiral analysis of STM indicated that all residues
were the L stereoisomer (Table S2). Resonances of the spin sys-
tems were assigned primarily by analysis of TOCSY, HSQC, and
HMBC experiments; intraresidue connectivity was established
by TOCSY and DQF-COSY.
Importantly, initial MS/MS analysis provided a partial
sequence of the C-terminal 11 residues of the peptide (resi-
dues 10–21): Ile/Leu-Ile/Leu-Gly-Tyr-Pro-Ala-Ile/Leu-Ile/Leu-
Val-Ile/Leu-Tyr-Pro (Figure 1B; Figure S2). This sequence
was supported by the HMBC/NOESY data (Figure S3). Inter-
estingly, additional MS/MS fragmentation was not seen N-ter-
minal to this sequence. Moreover, the FT-MS data supported
a chemical formula of C107H160N22O30 with an error of <1 ppm,
corresponding to the above 21 amino acids with the loss of a
single H2O. Integration of the
1H NMR spectrum taken in
CD3OH revealed that all the backbone amide resonances cor-
responded to a single proton each, with the absence of a free
N-terminal amine (Figure 2A). Taken together with the lack of
MS/MS fragmentation, this indicated that the nine N-terminal
residues were cyclized. Analysis of NOESY spectra revealed
one of the Asx residues identified earlier to be Asn; the other
residue displayed a strong nuclear Overhauser effect (NOE)
correlation to one of the Ser NH resonances, and was thusvier Ltd All rights reserved
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Figure 2. NMR Analysis
(A) Integrations of amide protons from the 1H NMR spectrum in CD3OH indi-
cate a single NH proton is present for each residue. Residue assignments are
shown above the spectrum. Peaks (ppm) are shown above the residue as-
signments. Integrations are shown below the spectrum.
(B) Expansion of the 1H-1H NOESY spectrum in CD3OD showing amide/side
chain through-space correlations. The isopeptide Ser1-Asp9 linkage is indi-
cated by the strong NOE cross peak between the Ser1 NH and the b protons of
Asp9, as highlighted in red.
(C) Overlaid 1H NMR spectra taken in CD3OD shortly after sample dissolution
(black) and 1 day later (red). Residue assignments are shown above the
spectrum. Significant resistance to deuterium exchange is evident for many
peaks.
See also Figure S3 and Table S1.assigned as a Ser-Asp isopeptide linkage, forming a nine-res-
idue ring (Figure 2B).
To establish the amino acid sequence of the nine-residue ring,
we first treated STM with carboxypeptidase Y. Although this did
not result in complete C-terminal tail truncation, the enzymatic
digestion yielded a mixture primarily containing three products
wherein either residues 11–21, 18–21, or 19–21 were removedChemistry & Biology 22, 241to give N-terminal macrocycle-containing fragments of 10, 17,
or 18 residues, respectively. The 10-residue peptide was further
treated with thermolysin, providing a linearized fragment of STM.
The MS/MS fragmentation pattern of digested STM allowed
partial sequence assignment of the N terminus and supported
the presence of the isopeptide Ser-Asp linkage (Figure 1C;
Figure S2).
With the constituents of the macrocycle established, we
sought to fully assign the sequence. Using HMBC and NOESY
correlations, each of the NMR spin systems identified earlier
was unambiguously assigned, clarifying the identity of the tripli-
cate residues (Tyr, Ser, Pro) andMS-ambiguous Ile/Leu residues
and confirming the assigned sequence within the ring (Figure S3;
Table S1). In conjunction, we also sequenced the full genome
of S. alba YIM 90003 (see later). Using our primary sequence
obtained spectometrically as a query in a TBLASTN search,
we identified a peptide encoded in the S. alba genome whose
C-terminal 21 residues corresponded to our structure, thereby
corroborating our sequence assignment (Figures 3A and 4).
Three-Dimensional Solution Structure of
Streptomonomicin
Two aspects of the NMR data pointed to a highly ordered three-
dimensional structure. First, many amide protons in the ring and
the N-terminal half of the tail showed resistance to deuterium
exchange (Figure 2C). Second, a large number of long-range
NOE correlations were apparent, particularly from the methyl
group of Ala15 to a number of the ring residues (e.g. Ser1,
Ser5, Tyr7, Asn8, Asp9) (Figures S3D and S3J). Additionally,
the ring/tail topology is characteristic of lasso peptides, a
class of conformationally constrained peptidic natural products
wherein a 7- to 9-membered N-terminal ring is nearly always
threaded by a C-terminal tail; this conformational lock protects
them to a degree from degradation and has resulted in recent in-
terest in these scaffolds (Arnison et al., 2013; Blond et al., 2002;
Maksimov et al., 2012). However, lasso peptide conformation
cannot be assumed from sequence alone because one recently
described lasso peptide is reported to be unthreaded (Gavrish
et al., 2014). As such, we sought to determine the three-dimen-
sional solution structure of STM.
Using NOE distance constraints derived from the NOESY
spectra and dihedral angle restraints extracted from the DQF-
COSY, an ensemble solution structure was calculated using
XPLOR-NIH (Figures 3B and 3C; Figure S4 and Table S3) (Protein
Data Bank [PDB] ID 2MW3). The resulting STM structure con-
tains the characteristic right-handed lasso; the ring encircles
the tail between residues 14 and 16 (Figure 3B). The constrained
ring and loop of STM are well ordered (0.26 A˚ root-mean-square
deviation [rmsd] against the lowest conformer for the backbone
for residues 1–17) and occlude solvent from inward-oriented
amide protons, rationalizing the observed slow deuterium ex-
change of many residues of the ring and the N-terminal half
of the tail (Figures 2C and 3C). The C-terminal portion of the
tail (residues 18–21) is more disordered, consistent with the
observed rapid deuterium exchange (Figure 2C). In lasso pep-
tides without disulfide bonds, bulky residues on the tail immedi-
ately flanking the ring serve as steric locks (Maksimov and Link,
2014) (Table S4). Inspection of the van der Waals surface of the
ring (residues 1–9) and the tail residues that thread the ring–250, February 19, 2015 ª2015 Elsevier Ltd All rights reserved 243
Figure 4. Biosynthetic Gene Cluster for Streptomonomicin
Streptomonomicin’s gene cluster architecture closely resembles that of
lariatin. The stm operon containing the biosynthetic gene cluster for STM
(stmABCDE) is shown above the characterized larABCDE gene cluster
responsible for lariatin production in Rhodococcus jostii. Several genes, stmF-
M, are present in the operon but have not been predicted to be required for
biosynthesis. Predicted function/homology is indicated in Table 1 and Fig-
ure S10. See also Figure S6 and Table S5.
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Figure 3. Structure of Streptomonomicin
(A) Schematic representation of the structure of STMwith the isopeptide Ser1-
Asp9 linkage indicated. Residues 1–9 (gray) comprise the ring and residues
10–21 (white) are the tail.
(B) Ensemble of the 15 lowest energy conformers of NMR solution structure;
backbone atoms are depicted.
(C) Stereo view of one conformer of STM with side chains shown. Backbone
atoms are depicted in red for the ring and blue for the tail. Side chains are
depicted in orange for residues 14–16, which thread the ring.
Images in (B) and (C) were generated using PyMOL. See also Figures S4 and
S5 and Tables S2–S4.suggests that Leu16 serves as this steric lock, preventing the
ring from unthreading (Figure 3C; Figure S5A). Ala15 is in close
contact with the ring but is unlikely to be bulky enough to prevent
unthreading. Pro14 may also play a role in biasing the conforma-
tion of the tail, although mutational studies would be necessary
to confirm this. Threaded lasso peptides are typically resistant
to carboxypeptidase Y digestion (Hegemann et al., 2013; Zim-
mermann et al., 2013); in contrast, STM is unusually susceptible
(see earlier). However, the complete tail digestion expected for
unthreaded lasso peptides was not observed, and a mixture of
partially truncated peptides was instead obtained. We hypothe-
size that the comparatively small steric lock of STM (Leu/Ala)244 Chemistry & Biology 22, 241–250, February 19, 2015 ª2015 Elsecombined with its large, nine-member macrocycle render it
more prone to proteolysis.
Unlike other lasso peptides, STM is unusually hydrophobic,
consisting of 5% hydrophilic and 52% hydrophobic residues.
Known class II lasso peptides (those without disulfide bonds,
like STM) are 10%–43% hydrophilic and almost always contain
a charged residue (Table S4). Interestingly, STM’s amino acid
composition is closer to that common for class I and III lasso pep-
tides (those conformationally restrained by two or one ring-tail
disulfide bonds, respectively). RP-71955, the siamycins, and
BI-32169, like STM, contain 5% hydrophilic and 43%–53% hy-
drophobic residues, being rich in Leu/Ile/Val/Ala (Table S4). Addi-
tionally, despite little primary sequence identity, the structure of
STM aligns closely (backbone rmsd 1.03 A˚ for residues 1–17
against the lowest energy conformer of STM) to the crystal struc-
ture of BI-32169 (PDB ID 3NJW), a lasso peptide of streptomy-
cete origin (Knappe et al., 2010; Nar et al., 2010) (Figure S5B).
Markedly, although a Ser-Glu isopeptide linkage has recently
been reported in the caulonodins, no lasso peptide with a Ser-
Asp isopeptide linkage was formerly known (Zimmermann
et al., 2014). Before the caulonodins and STM, it was thought
that the first residue of lasso peptides was invariantly Gly or
Cys, as amino acid substitutions at this site had not been found
in nature; even conservative substitutions at this site were not
tolerated by the enzymatic machinery for microcin J25, capi-
struin, or astexin-1, for instance (Knappe et al., 2009; Pavlova
et al., 2008; Zimmermann et al., 2013).
Biosynthetic Gene Cluster for Streptomonomicin
Lasso peptides belong to a class of ribosomally synthesized and
post-translationally modified peptides (RiPPs) whose biosyn-
thetic enzymes and precursor peptides are readily identified
through bioinformatic analysis (Arnison et al., 2013). The biosyn-
thesis of highly ordered lasso topologies like that of STM is a
compelling topic of study because of the general inaccessibility
of such structures by chemical peptide synthesis. In the interest
of characterizing STM’s biosynthetic origin and shedding light on
the biosynthetic potential of the genus Streptomonospora, we
performed whole-genome sequencing of S. alba YIM 90003.
This revealed a gene cluster (stm) containing biosynthetic genes
(stmABCDE) homologous to those known to be involved invier Ltd All rights reserved
Table 1. List of Stm Proteins
CDS Size (aa)
Lar homolog
(identity, %/aa
length coverage) Proposed function (Pfam)
StmA 41 LarA (34/35) Precursor peptide
StmC 628 LarB (25/538) Lasso peptide cyclase
(PF00733)
StmE 87 LarC (28/83) Unknown (PF05402)
StmB 143 LarD (35/107) Lasso peptide protease
(PF13471)
StmD 628 LarE (34/590) ABC transporter (export;
PF00005, PF00664)
StmF 248 – ABC-type multidrug transport
system (PF00005)
StmG 224 – ABC-2 family transporter
(PF12730)
StmH 250 – ABC-2 family transporter
(PF12730)
StmI 190 – Hypothetical, no identifiable
homologs
StmJ 253 – Hypothetical, no identifiable
homologs
StmK 204 – Hypothetical, no identifiable
homologs
StmL 209 – Response regulator (PF00072,
PF00196)
StmM 418 – Signal transduction histidine
kinase (PF07730, PF02518)
Proteins are depicted along with identified biosynthetic roles based on
homology to characterized enzymes in the lariatin biosynthetic cluster.
For proteins without LarABCDE homologs, proposed functions are
given based on homologous gene families; Pfam domains are given in
parentheses.
Table 2. Spectrum of Antimicrobial Activity for
Streptomonomicin
Strain MIC (mg/ml) MIC (mM)
Bacillus anthracis str. Sterne DLF 4 2
Bacillus anthracis str. Sterne 8 4
Bacillus halodurans 8 4
Bacillus cereus ATCC 4342 8 4
Bacillus cereus ATCC 13472 16 7
Bacillus sp. Al Hakam 16 7
Bacillus subtilis 64 29
Listeria monocytogenes 32 14
Enterococcus faecalis 64 29
Staphylococcus aureus 128 57
Mycobacterium smegmatis >128 >57
Escherichia coli >128 >57
Pseudomonas putida >128 >57
Saccharomyces cerevisiae >128 >57
Talaromyces stipitatus >128 >57
Aspergillus niger >128 >57
Trichoderma longibrachiatum >128 >57
The top ten strains are bacteria from the Firmicutes phylum, which is
followed by a Mycobacterium. The next two species are from the Proteo-
bacteria phylum. The lowest four organisms are Ascomycota fungi.lasso peptide biosynthesis (Figure 4; Table 1; Figure S6). Of the
characterized lasso peptide gene clusters, stmABCDE most
resemble larABCDE, the genes in Rhodococcus jostii K01-
B0171 responsible for production of lariatin (Inokoshi et al.,
2012); however, we have annotated the STM gene cluster in
agreement with the community consensus (Arnison et al.,
2013). The gene stmA encodes the 41-residue precursor peptide
(StmA) comprised of a 20-amino acid N-terminal leader
sequence and the 21-member C-terminal core peptide that is
subsequently modified to give the mature natural product.
StmB is a transglutaminase homolog; its homologs in lasso pep-
tide gene clusters are believed to function as ATP-dependent
cysteine proteases implicated in leader peptidolysis. StmC is ho-
mologous to asparagine synthase B and putatively catalyzes
macrolactam formation via adenylation of the Asp9 side chain,
activating it toward nucleophilic attack by the N terminus of the
core peptide. StmD is an ATP-binding cassette (ABC) trans-
porter likely involved in exporting the mature STM product.
Last, StmE is homologous to a protein of unknown, but essential,
function that is present in the lariatin biosynthetic cluster but not
in the clusters for capistruin or microcin J25 (Inokoshi et al.,
2012; Maksimov and Link, 2014). In addition to the requisite
biosynthetic machinery, the stm cluster includes a number ofChemistry & Biology 22, 241other genes stmF-M (Figure 4; Figure S6). Although these genes
have not previously been reported, they are conserved across a
series of additional predicted lasso peptide gene clusters
(Figure S6).
Analysis of Biosynthetic GeneClusterswithin theS. alba
Genome
Streptomonospora resides in the Streptosporangiales, a subor-
der of the Actinobacteria; these organisms, based on a survey
of 14 known genomes, harbor on average about 15 natural prod-
uct biosynthetic gene clusters, although some appear to contain
zero (Doroghazi et al., 2014). Using the bioinformatics-based
prediction algorithm antiSMASH (Blin et al., 2013; Medema
et al., 2011), we analyzed the genome of S. alba to evaluate its
biosynthetic repertoire. This revealed the presence of at least
11 other putative biosynthetic gene clusters, including those
containing terpenoid, type I and III polyketide synthase, nonribo-
somal peptide synthase, lanthipeptide, and thiopeptide machin-
ery (Table S5). As the biosynthetic capability of an organism has
been closely linked to phylogeny (Doroghazi et al., 2014), this
result suggests by extension that the genus Streptomonospora
harbors the ability to produce a diverse array of secondary
metabolites.
Streptomonomicin Bioactivity and Resistance
STM’s antibiotic activity was tested against a panel of Gram-
positives, Gram-negatives, and fungal species via a microbroth
dilution assay (Table 2). Although STMwas inactive against fungi
and Gram-negatives, it was active against several Gram-posi-
tives. STM most potently inhibited the growth of Bacillus anthra-
cis, the causative agent of anthrax, with minimum inhibitory
concentrations (MICs) of 2–4 mM. MICs against other members–250, February 19, 2015 ª2015 Elsevier Ltd All rights reserved 245
AB C
Figure 5. Bioactivity of Streptomonomicin
(A) Growth curve (595 nm absorbance) depicting the effect of addition of STM
to wild-type B. anthracis str. Sterne DLF. Cultures were grown at 37C to
midexponential phase (OD600 = 0.4) before the addition of 13, 23, or 43MIC
of STM.
(B) Wild-type B. anthracis forms chains of usually fewer than eight cells under
standard culturing conditions, as shown by DIC microscopy.
(C) A representative DIC image of one STM-resistant mutant (WalR-H215P)
shows the resistant strains display an exaggerated chaining phenotype.
Scale bars, 10 mm. See also Figure S7 and Table S5.of the Bacillus genus ranged from 4 to 7 mMwith the exception of
B. subtilis (29 mM). Weak activity was seen against other Firmi-
cutes. A time course growth curve of B. anthracis str. Sterne
challenged at midexponential phasewith STM showed an imme-
diate cessation of growth upon addition of the compound (Fig-
ure 5A). Additionally, the minimum bactericidal concentration
was determined to be 24 mM.
To gain preliminary insight into the mechanism of action
by means of investigating bacterial resistance to STM, we
selected STM-resistant mutants in B. anthracis. Whole-genome
sequencing revealed that all resistant strains harboredmutations
to walR, including five instances in the coding region and one in
the region upstream of walR (Figure S7A). WalR, a response
regulator, forms a two-component regulatory system (TCS)
with the histidine kinase WalK, which in characterized cases
(e.g. B. subtilis) controls genes related to cell wall metabolism
and cell division (Dhiman et al., 2014; Dubrac and Msadek,
2008). In the WalK/WalR TCS, formerly known as YycG/YycF
(Dubrac and Msadek, 2004), the membrane-associated WalK
is involved in extracellular signal sensing and subsequent His
autophosphorylation. This phosphoryl group is then transferred
to a conserved aspartate (Asp54) in WalR, a cytosolic response
regulator composed of an N-terminal receiver domain (contain-246 Chemistry & Biology 22, 241–250, February 19, 2015 ª2015 Elseing Asp54) and a C-terminal DNA-binding effector domain. Tran-
scription is activated by the dimeric binding of the activated
response regulator to specific repeated DNA sequences and to
RNA polymerase (Dubrac and Msadek, 2008). The WalK/WalR
TCS is highly conserved in Firmicutes and been shown to be
the only widely distributed TCS essential for cell viability (Dubrac
and Msadek, 2008; Fabret and Hoch, 1998). Although no formal
demonstration of essentiality has been reported for B. anthracis,
it is generally thought that WalK/WalR is essential in Firmicutes
(Dubrac and Msadek, 2008).
Three of the substitutions (V176P, H215P, P216S) in our
STM-resistant strains are in the DNA-binding domain of WalR,
whereas two substitutions (D84Y, D88N) are in the receiver
domain (Figure S7C). Homology modeling with MtrA (PDB ID
2GWR; 50% identity to WalR) allowed visualization of the point
mutation locations (Arnold et al., 2006; Biasini et al., 2014). In
the receiver domain, Asp84 and Asp88 are located on the
same surface in spatial proximity to the active site, Asp54, but
distant enough that the mutants would be expected to remain
somewhat functional (ca. 14 and 10 A˚, respectively) (Figure S7D).
In the effector domain, which adopts a winged helix-turn-
helix DNA-binding motif, two of the mutated residues (His215,
Pro216) are found in the a3-b5 loop immediately following the
a2/a3 helix-turn-helix motif (Figure S7D); this loop (especially
Ser214-Pro216) has been previously implicated in DNA binding
(Doi et al., 2010). The other mutated residue (Val176) is found
immediately preceding the helix-turn-helix (Figure S7D).
WalR substitutions have previously been shown to correlate to
growth defects or perturbation in protein function. WalR bearing
a H215A or H215P substitution exhibits significantly attenuated
DNAbinding, andB. subtiliswithWalR-H215P is thermosensitive
(Doi et al., 2010; Fabret and Hoch, 1998; Watanabe et al., 2003).
Amino acid changes in the helix-loop-helix region of WalR often
display phenotypes consistent with the alteration of cell wall
metabolism, including intermediate vancomycin resistance and
cell wall thickening (Hafer et al., 2012; Howden et al., 2011).
STM-resistant B. anthracis mutants displayed obvious pheno-
typic defects, including visible clumping of cells in liquid culture
and recalcitrance to pelleting by centrifugation. Differential inter-
ference contrast (DIC) microscopy revealed that STM-resistant
strains displayed extremely long chain lengths, indicative of a
septal cleavage defect (Figures 5B and 5C; Figure S7B). This
chaining phenotype in Bacillus sp. is well known from deletion
studies of particular autolysins (peptidoglycan hydrolases),
such as LytE (formerly CwlF), LytF, CwlS, and BslO (Anderson
et al., 2011; Fukushima et al., 2006; Hashimoto et al., 2012; Ishi-
kawa et al., 1998). In addition to cell separation, LytE, in collab-
oration with the CwlO autolysin, has been implicated in cell
elongation (Meisner et al., 2013).
Intriguingly, the WalK/WalR TCS in B. subtilis is known to con-
trol the expression of the autolysin lytE (Dubrac and Msadek,
2008; Fukuchi et al., 2000; Salzberg et al., 2013), and in
B. anthracis the predicted regulon also includes the cell division
ABC transporter ftsE (Dhiman et al., 2014); this suggests a
likely mechanism for the chaining phenotype displayed by
the STM-resistant strains. To confirm if the WalK/WalR TCS
in B. anthracis controls the expression of these genes, we
compared the expression levels between wild-type and STM-
resistant B. anthracis strains by qRT-PCR. These experimentsvier Ltd All rights reserved
confirmed that, relative to wild-type, the STM-resistant strains
downregulated both ftsE and lytE (Table S6). A similar analysis
of STM-treated wild-type B. anthracis showed an upregulation
of liaI and liaH, genes that are induced as part of the cell wall
stress regulon (Table S6) (Dominguez-Escobar et al., 2014;
Wolf et al., 2010). These combined data are consistent with
STM directly or indirectly inducing cell wall stress and with resis-
tance arising by a strategic, but costly, perturbation in cell wall
metabolism. Excitingly, this potential mechanism stands in
contrast to the antimicrobial activities of the lasso peptides for
which the mechanism of action has been characterized, which
target RNA polymerase (capistruin and microcin J25) or the
ATP-dependent ClpC1 protease (lassomycin) (Bellomio et al.,
2007; Gavrish et al., 2014; Kuznedelov et al., 2011). However,
as our data primarily relate to a resistant mechanism rather
than a direct target, further studies will be required to ascribe a
precise mechanism of action to STM.
SIGNIFICANCE
The discovery of streptomonomicin (STM) illustrates that
understudied laboratory-cultivable bacteria (here, Strepto-
monospora alba) remain sources of readily discoverable
natural products. The long cultivation times required for
the Streptomonospora, compared with most commonly
screened antibiotic producers, has limited their exploration.
Here,we report thefirstgenomesequenceof anyStreptomo-
nospora, revealing a diversity of biosynthetic gene clusters
and setting the stage for genome-guided discovery within
this genus. STM itself is significant from several perspec-
tives. First, it represents the first reported natural product
from Streptomonospora. Second, STM adopts a threaded
lasso peptide structure with an unprecedented isopeptide
linkage between Ser-Asp. Third, STM is among the most
hydrophobic of the lasso peptides and more hydrophobic
than any previously reported class II lasso peptide; hydro-
phobicity is linked to in vivo bioavailability and cell perme-
ability, and STM thus represents a potentially useful expan-
sion of lasso peptide chemical space. Fourth, STM exhibits
antibiotic activity against several Gram-positive organisms,
most notably Bacillus anthracis, the causative agent of
anthrax. Last, spontaneous resistant mutants to STM exhibit
visiblegrowthdefectsbymutations towalR, a geneencoding
a response regulator in a broadly distributed two-component
signal transduction system involved in cell wall metabolism,
which has been shown to be essential in several Gram-posi-
tive bacteria. Our data are consistent with STM inducing
cell envelope stress, suggesting a biological activity distinct
from the activities reported for all other lasso peptides.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions
Streptomonospora alba YIM 90003 was obtained from the USDA Agricultural
Research Service Culture Collection and grown on ISP medium no. 5 (1 l con-
tains 1 g of L-asparagine, 1 g of K2HPO4, 20 g of agar, 10 g of glycerol, 1 mg of
FeSO4$7H2O, 1 mg of ZnSO4$7H2O, 1 mg of MnCl2$7H2O) with 10% (w/v)
NaCl at 30C. Bacillus anthracis strain Sterne DLF, Bacillus anthracis strain
Sterne, Bacillus halodurans, Bacillus cereus ATCC 4342, Bacillus cereus
ATCC 13472, Bacillus sp. Al Hakam, Bacillus subtilis strain 168, EscherichiaChemistry & Biology 22, 241coli DH5a, Pseudomonas putida KT2440 were grown in Luria-Bertani (LB)
medium (1 l contains 10 g of NaCl, 5 g of yeast extract, 10 g of tryptone) at
37C. Listeria monocytogenes strain 4b F2365, Enterococcus faecalis U503
(vancomycin resistant), Staphylococcus aureus USA300 (methicillin resistant)
were grown in brain-heart infusion (BHI) medium at 37C. Mycobacterium
smegmatis was grown in ATCC medium no. 172 (1 l contains 10 g of glucose,
5 g of yeast extract, 5 g of N-Z Amine Type A, 20 g of soluble starch, 1 g of
CaCO3) at 30
C. Saccharomyces cerevisiae, Talaromyces stipitatus, Asper-
gillus niger, and Trichoderma longibrachiatum were grown in yeast extract-
peptone-dextrose (YPD) medium (1 l contains 10 g of yeast extract, 20 g of
peptone, 20 g of glucose) at 30C.
Evaluation of Bioactivity
The brothmicrodilution assay for determination ofMICwas used for evaluation
of STM activity. Bacterial strains were grown in 10 ml of their corresponding
medium at 37C to stationary phase. The cultures were adjusted to an optical
density at 600 nm (OD600) of 0.01 in fresh medium. STM was serially diluted 2-
fold in a 96-well microplate and an equal volume of prepared bacterial culture
was added to each well (final concentration of STM in wells ranged from 0.5 to
128 mg/ml [0.2–57 mM]; final volume, 100 ml/well). Plates were covered and
incubated at 37C with shaking. The MIC reported is the concentration of
STM that resulted in no visible growth after 18 hr.
Fungal strains S. cerevisiae, T. stipitatus, A. niger, and T. longibrachiatum
were grown in YPD medium for 48 hr at 30C. Cultures were diluted 1:100
into fresh medium. STM was serially diluted 2-fold in 96-well microplates
and an equal volume of fungal culture was added to each well (final concentra-
tion of STM in wells ranged from 0.5 to 128 mg/ml, 0.2–57 mM). Plates were
covered and incubated at 30Cwith shaking. The MIC reported is the concen-
tration of STM that resulted in no visible growth after 36 hr.
Mass Spectrometry
MALDI-TOF MS Analysis
Mass spectra were obtained using a Bruker Daltonics UltrafleXtreme MALDI-
TOF/TOF mass spectrometer in positive reflector mode. The instrument was
calibrated using a peptide calibration kit (AnaSpec Peptide Mass Standard
Kit). Samples (0.5 ml) were spotted on a steel plate with 3 ml of a-cyano-4-hy-
droxycinnamic acid matrix solution (sat., 1:1 MeCN/H2O containing 0.1%
trifluoroacetic acid [TFA]) and air-dried at room temperature. Data were
analyzed using flexAnalysis 3.3 (Bruker).
FT-MS/MS Analysis
STM was dissolved in 80% aq. MeCN containing 1% (v/v) formic acid (FA).
Using an Advion Nanomate 100, STM was directly infused into a Thermo
Scientific LTQ-FT hybrid linear ion trap operating at 11 T (calibrated weekly).
The FT-MS was operated using the following parameters: minimum target
signal counts, 5,000; resolution, 100,000; m/z range detected, dependent
on target m/z; isolation width (MS/MS), 5 m/z; normalized collision energy
(MS/MS), 35; activation q value (MS/MS), 0.4; activation time (MS/MS),
30 ms. Data were analyzed using the Qualbrowser application of Xcalibur
(Thermo Scientific).
Screening of Cell Extract
S. albawas grown on ISPmedium no. 5 containing 10% (w/v) NaCl for 21 days
at 30C. Exported metabolites were extracted from cells using 70% aq. MeOH
at room temperature for 1 hr. The intact cells were removed by centrifugation
(4000 3 g, 10 min), and the extract was analyzed by MALDI-TOF MS.
Purification of Streptomonomicin
S. albawas grown on agar plates of ISPmedium no. 5 containing 10%NaCl for
30 days at 30C (90 plates 3 15 cm diameter; 5 l in total, performed in 5 por-
tions). Plates were air-dried for 2 days and exported metabolites were ex-
tracted with MeOH (2 l) for 12 hr. The extract was centrifuged (4000 3 g,
10 min), filtered, and dried by rotary evaporation. The dried material was dis-
solved in 25% aq. MeOH (500 ml), filtered, loaded onto a Waters Sep-Pak
C18 cartridge (125 A˚ pore size; 2 g sorbent; 55–106 mm particle size), and
washed with 20% aq. MeCN (ca. 100 ml) containing 0.1% (v/v) TFA. The
STM-containing fraction was eluted with 60% aq. MeCN containing 0.1%
(v/v) TFA (20 ml). Subsequent purification employed an Agilent 1200
HPLC system outfitted with a Thermo Scientific Betasil C18 column (100 A˚;–250, February 19, 2015 ª2015 Elsevier Ltd All rights reserved 247
250 3 10 mm; 5 mm particle size) operating at 4.0 ml/min. The column was
equilibrated with 5% aq. MeCN containing 0.1% (v/v) FA and purified via a
linear gradient of 5%–60% aq. MeCN containing 0.1% (v/v) FA over 40 min.
Absorbance wasmonitored at 220 nm. The STM-containing fraction was dried
using a vacuum concentrator to afford a slightly yellow solid (yields ranged
from 10 to 14 mg/l of medium, 0.6–0.8 mg/plate).
Protease Treatment
Purified STM (100 mg) was treated with 0.5 U of carboxypeptidase Y (from
baker’s yeast; Sigma-Aldrich) in a buffer containing 50 mM MES and 1 mM
CaCl2 at pH 6.7 for 6 hr at 25
C. The reaction mixture was then purified
with an Agilent 1200 HPLC system outfitted with an Agilent G1956B single
quadrupole mass analyzer and a Thermo Scientific Biobasic C18 column
(300 A˚, 250 3 4.6 mm, 5 mM particle size) operating at a flow rate of
1.0 ml/min and separated with a linear gradient of 5%–60% aq. MeCN con-
taining 0.1% (v/v) FA over 40 min. Absorbance was monitored at 220 nm.
Fractions were collected manually and analyzed by MALDI-TOF MS. The frac-
tion containing a mass ion of m/z 1057.1 ([M + Na]+) was dried, dissolved in
100 ml of buffer solution (50 mM Tris-HCl [pH 8], 100 mM NaCl), and digested
by thermolysin (from Bacillus thermoproteolyticus rokko; Sigma-Aldrich) (1 U)
for 1 hr at 37C. The products of the reaction were separated by HPLC using a
Biobasic C18 column (300 A˚, 250 3 4.6 mm, 5 mM particle size) (Thermo Sci-
entific) operating at a flow rate of 1.0 ml/min with a linear gradient of 5%–60%
aq. MeCN containing 0.1% (v/v) FA over 40 min. Fractions were collected
manually, screened by MALDI-TOF MS, concentrated, and analyzed by FT-
MS/MS.
NMR Spectroscopy
Samples were prepared by dissolving ca. 4 mg of STM (HPLC-purified and
lyophilized) in 500 ml of either methanol-d4 (CD3OD; 99.96 atom % D;
Sigma-Aldrich) or methanol-d3 (CD3OH; 99.8 atom % D; Sigma-Aldrich).
NMR spectra were recorded on an Agilent VNMRS 750MHz narrow boremag-
net spectrometer equipped with a 5 mm triple resonance (1H-13C-15N) triaxial
gradient probe and pulse-shaping capabilities. Samples were held at 25C
during acquisition. Standard Varian pulse sequences were used for each of
the following experiments: 1H, 1H-1HDQF-COSY, 1H-1H TOCSY (80msmixing
time), 1H-13C HSQCAD, 1H-13C HMBCAD, and 1H-1H NOESY (400 ms mixing
time). Solvent suppression by presaturation (PRESAT) was employed when
CD3OH was used as the solvent. Spectra were recorded with VNMRJ 3.2A
software and data were processed using MestReNova 8.1.1, nmrPipe (Dela-
glio et al., 1995), and Sparky (Goddard and Kneller). Resonances were refer-
enced internally to the solvent peak (3.30 ppm, methanol).
Structure Calculations
STM’s solution structure was calculated by simulated annealing using dis-
tance and angle restraints within XPLOR-NIH v 2.36 (Schwieters et al., 2003,
2006). Standard XPLOR-NIH potentials for bond angles, improper angles,
van der Waals, and favored/allowed Ramachandran regions were used. The
Ser1-Asp9 isopeptide linkage was generated using a manual patch of the
‘‘protein1.0.top’’ XPLOR-NIH file (Supplemental Experimental Procedures).
Distance restraints were derived from peak area integrations in the NOESY
data sets, which were binned into specific distance categories (2.5, 3.5, 5.0,
and 6.0 A˚). nmrPipe was used for processing of raw NOESY data and conver-
sion from Varian to UCSF format (Sparky), and Sparky was used for peak pick-
ing, volume integration, and creation of the XPLOR distance restraint table.
Peptide backbone dihedral restraints were derived from coupling constants
determined from DQF-COSY. Three hundred structures were calculated, of
which the 15 structures of lowest energy were chosen for structural analysis.
The quality of the NMR structures was evaluated using PROCHECK-NMR
(Laskowski et al., 1993; Laskowski et al., 1996). A list of the number and
type of restraints used (Table S3) and the PROCHECKquality report (Figure S4)
are given in the Supplemental Information.
Generation of Resistant Mutants
Six independent cultures (10 ml) of B. anthracis str. Sterne DLF were grown
overnight in LB medium at 37C. A portion (100 ml) of each culture was spread
onto LB agar plates containing 4, 7, or 14 mMSTM. The plates containing 4 mM
STM yielded resistant mutants after 24 hr of incubation at 37C. No bacterial248 Chemistry & Biology 22, 241–250, February 19, 2015 ª2015 Elsegrowth was detected at higher concentrations of STM after 48 hr. The MIC
of all six STM-resistant strains was 7 mM and was obtained as described
above.
Whole-genome Sequencing
Genomic DNA fromS. alba YIM 90003 as well as wild-type and four STM-resis-
tantmutants ofB. anthracis str. SterneDLFwas isolatedusing anUltraCleanMi-
crobialDNAIsolationKit (MOBIO). Theshotgungenomic librarieswere thenpre-
pared with an Illumina-Compatible KAPA DNA Library Preparation Kit (Kapa
Biosystems). Paired-end sequencing with read length 100 nt was conducted
by the Roy J. Carver Biotechnology Center (University of Illinois, Urbana, IL,
USA) using an Illumina HiSeq2500. The genome of S. alba YIM 90003 was
assembledandmappedwithCLCAssemblyCell software (CLCbio) anddepos-
ited in GenBank. Breseq software was used for finding mutations in the ge-
nomes of wild-type and STM-resistant mutants, relative to a reference genome
(AE017225 for chromosomal DNA andNC_007322 for pXO1 plasmid) (Deather-
ageandBarrick, 2014).Nucleotide substitutions thatwerepresent inSTM-resis-
tant mutants but not in the wild-type strain, in comparison with the reference
genome, were identified and verified with PCR amplification and Sanger
sequencing. Nucleotide substitutions in two STM-resistant mutants whose ge-
nomes were not sequenced were identified by Sanger sequencing alone.
Microscopy
Stationary-phase cultures of B. anthracis str. Sterne DLF (wild-type and STM-
resistant strains) were used to inoculate LBmedium (200 ml into 5 ml). Cultures
were grown to an OD600 of 0.5 before an aliquot (1 ml) was removed, harvested
by centrifugation, and resuspended in 250 ml of PBS. Due to the abnormal
growth of the STM-resistant mutants, the wild-type culture was used to deter-
mine cell density. Ten microliter aliquots of each resuspended culture were
combined with 10 ml of liquefied low gelling temperature agarose (10 ml, 2%)
on a microscope slide. Cell morphology was analyzed by DIC microscopy.
DIC microscopy analyses were conducted using a Zeiss LSM 700 confocal
microscope outfitted with a 405 nm laser. Linear contrast was applied when
deconvoluting images in ZEN 2012 software (Carl Zeiss).
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